LegiList
Congress, Made Clear.
Congress
Disclosures
Insights
My LegiList
Support LegiList
Legislators
Bills
Laws
Committees
Campaign Finance
Lobbying
Analytics
Weekly Briefing
Congress
Legislators
Bills
Laws
Committees
Disclosures
Campaign Finance
Lobbying
Insights
Analytics
Weekly Briefing
My LegiList
Support LegiList
For past Congresses, use the Browse menu.
Home
›
Bills
›
HR 2337
›
Lobbying
HR 2337
114th Congress • 2015–2017 (Ended)
To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices.
Full Bill Page
Lobbying Summary
Organizations below reported lobbying activity that included this bill as a disclosed issue. Expand to view filing details.
Loading filings…